-
FDA approves update to Takeda cancer drug label
CAMBRIDGE, Mass. — The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.
Takeda and Millennium, the Japanese drug maker's cancer-drug subsidiary, announced Tuesday that the FDA approved a supplemental new drug application for the injectable multiple myeloma drug Velcade (bortezomib) that updates its label to include additional data from a clinical study showing that the drug extended patients' survival time.
-
Report: Meth cooks credited with 80% increase in PSE sales
ST. LOUIS — There has been a sharp increase in sales of pseudoephedrine products just outside St. Charles County, Mo., which implemented a prescription requirement on the sale of PSE beginning Aug. 30, according to an article in the St. Louis Post-Dispatch published Monday that cited data from Det. Sgt. Jason Grellner, past president of the Missouri Narcotics Officers Association.
According to that data, sales of PSE products were up 81% in September versus August in Bridgeton, Mo., and increases in Maryland Heights and Chesterfield were 59% and 51%, respectively.